Jerini Overview

  • Founded
  • 1984
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 65
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $545M
Latest Deal Amount

Jerini General Information

Description

Developer and marketer of peptide-based drugs. The company offers Firazyr (Icatibant) for the treatment of acute attacks of hereditary angioedema. Its developing product pipeline includes JSM 6427, a a5ß1 Integrin antagonist for the treatment of cancer, age-related mascular degeneration-blindness in the elderly, and angiogenesis, inflammation, and fibrosis; and JSM-7717 and JPE-1375, which are C5a receptor antagonists for the treatment of inflammatory and ophthalmological diseases.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Invalidenstrasse 130
  • 10115 Berlin
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jerini Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Jul-2008 $545M 00000 00000 Completed Generating Revenue
3. IPO 01-Nov-2005 000.00 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 09-Jun-2004 $37.5M $42.9M Completed Generating Revenue
1. Early Stage VC (Series A) $5.44M $5.44M Completed
To view Jerini’s complete valuation and funding history, request access »

Jerini Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jerini Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
Edelman Financial Services Asset Manager Minority 000 0000 000000 0
HealthCap Venture Capital Minority 000 0000 000000 0
IBB Beteiligungsgesellschaft Venture Capital Minority 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »